US 12,424,326 B2
Systems, devices, and methods for episode detection and evaluation
Gary A. Hayter, Oakland, CA (US); Timothy C. Dunn, San Francisco, CA (US); Nathan Crouther, San Francisco, CA (US); Daniel M. Bernstein, El Granada, CA (US); and Eric L. Davis, Castro Valley, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Apr. 9, 2021, as Appl. No. 17/226,636.
Application 17/226,636 is a continuation of application No. 15/573,736, granted, now 11,004,566, previously published as PCT/US2016/041014, filed on Jul. 5, 2016.
Claims priority of provisional application 62/191,208, filed on Jul. 10, 2015.
Claims priority of provisional application 62/189,137, filed on Jul. 6, 2015.
Prior Publication US 2021/0225524 A1, Jul. 22, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 5/145 (2006.01); G06F 11/362 (2025.01); G06F 30/20 (2020.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01)
CPC G16H 50/30 (2018.01) [A61B 5/0004 (2013.01); A61B 5/14532 (2013.01); A61B 5/7275 (2013.01); A61B 5/7282 (2013.01); A61B 5/7435 (2013.01); A61B 5/7475 (2013.01); G06F 11/366 (2013.01); G06F 30/20 (2020.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 40/67 (2018.01); A61B 5/4839 (2013.01)] 22 Claims
OG exemplary drawing
 
1. An analyte monitoring system for use in episode detection and evaluation, the system comprising:
a sensor control device comprising a sensor adapted to obtain a measurement of an analyte level of a patient and wireless communication circuitry adapted to communicate the measurement of the analyte level to a reader device; and
the reader device comprising;
a display;
wireless communication circuitry adapted to receive the measurement of the analyte level from the sensor control device;
processing circuitry communicatively coupled with the wireless communication circuitry, the display, and a non-transitory memory; and
the non-transitory memory having stored thereon a plurality of first instructions that, when executed by the processing circuitry, cause the processing circuitry to:
transmit the received measurement of the analyte level to a server;
in response to receiving an indication of an episode, cause the display of a prompt related to the episode, a text entry field for a customized response, and a picklist of one or more responses that are selectable in response to a determination that an episode has occurred;
receive a response to the prompt related to the episode regarding a potential cause of the episode;
implement a modification to the picklist, wherein the modification is at least one of: the addition to the picklist of the customized response that is selectable or the deletion of a response from the picklist; and
recommend an adjustment to medication therapy based on the determined episode; and
the server comprising:
one or more processors coupled with a memory having stored thereon a plurality of second instructions, wherein the second instructions, when executed by the one or more processors, cause the one or more processors to:
determine whether the measurement of the analyte level indicates that the episode has occurred; and
transmit the indication of the episode to the reader device; and
an insulin delivery device configured to administer the recommended adjustment to the medication therapy.